@PSchauerMD

Professor of Metabolic Surgery, Director Metamor Institute, Pennington Biomedical Research Center of Louisiana State University

Baton Rouge, LA
Joined September 2015
Philip Schauer, MD retweeted
Early obstruction after gastric bypass? A new systematic review describes 29 clot-related JJ obstructions, usually within 72 hours. Rare, but worth remembering when obstruction and bleeding coexist. Evidence is retrospective. link.springer.com/article/10…
1
5
224
Philip Schauer, MD retweeted
In an 88,689-case TriNetX analysis, 29% of sleeve-associated portomesenteric thromboses were diagnosed after week 4; a 30-day window misses part of the burden. Anticoagulant data were unavailable. Disclosure: Dr. Schauer is a coauthor. MBS Digest Vol. 2, Issue 15. Link in reply.
1
1
2
86
Philip Schauer, MD retweeted
MBS Digest Vol. 2, Issue 15: bariatric surgery and cancer incidence in 784,105 Nordic adults (aIRR 0.81; pancreatic cancer 1.19); 29% of sleeve-associated portomesenteric thromboses diagnosed after week 4; 12-year RYGB mortality 4.34% vs 7.11%. Link in reply.
1
1
1
40
Philip Schauer, MD retweeted
A patient with obesity does not arrive as a surgical problem or a medication problem. MBS Digest is changing its name to match: it is now the Metabolic and Bariatric Sciences Digest. Same MBS, same weekly briefing, a wider view of the evidence.
1
3
8
250
Philip Schauer, MD retweeted
MBS Digest has a new full name: the Metabolic and Bariatric Sciences Digest. The initials, the weekly briefing and the editorial board stay the same. Surgery remains central; the name now covers the full range of obesity care our readers work in.
1
1
1
26
Philip Schauer, MD retweeted
There’s still time to join us November 5-7 in Las Vegas for ASMBS Weekend 2026! Registration is open, and rooms are still available at Paris Las Vegas at the current hotel rate. Register today: asmbeweekend.com We hope to see you there! #ASMBSWeekend #ASMBS
1
2
3
329
Philip Schauer, MD retweeted
Replying to @DrAdrianDan
@DrAdrianDan at @ASMBS Ohio Chapter Conference
1
15
650
Philip Schauer, MD retweeted
METABOLIC BARIATRIC SURGERY (MBS) achieves the best long-term results when it is part of a comprehensive, multidisciplinary care plan. Coordinated care improves safety, outcomes, and quality of life for patients
3
8
309
Philip Schauer, MD retweeted
October is #BreastCancerAwareness Month When women have a better self-image, they are more physically active which may reduce their risk of chronic health issues…including reducing their risk of breast #cancer recurrence. bit.ly/3KVfcPi @Hologic #MediflixOriginal
1
1
62
Philip Schauer, MD retweeted
Weight recurrence deserves a careful revision discussion, not an automatic trip back to the OR. ASMBS is highlighting its Weekend session, ‘Just One More Hand: Weight Recurrence Revisions.’ Education, not a new outcomes study. xitter.cf/ASMBS/status/211040105…
1
2
44
Philip Schauer, MD retweeted
Great experience at #SPCO in beautiful Porto 🇵🇹! Shared my vision, IFSO’s strategy, and the future of AI in obesity care. Thanks to SPCO 🇵🇹 President John Preto and @aec_obesidad SECO 🇪🇸 President Fátima Sabench for their leadership and collaboration! Porto will host #IFSO European Chapter 2029! @IFSO_NAC @IFSOMENAC @IfsoSecretariat @ifso_ec @IFSOLAC @JNJMedTech @Medtronic @IntuitiveSurg @bostonsci @EliLillyandCo
🤖 Made with AI
3
5
362
Approximately 1 in 4 active-duty male U.S. Army personnel may have a morning testosterone measurement below a commonly used clinical threshold, according to new research from Pennington Biomedical Research Center published this week in JAMA. The findings provide estimates of low testosterone screening results across the active-duty Army population and offer insight into the potential implications of routine testosterone screening for military personnel. To view the full article, visit hubs.ly/Q04Bh-_h0
2
4
180
Can AI and wearable tech help teens build healthier habits? 📱 A new Pennington Biomedical pilot study explored technology-assisted summer obesity prevention. Read more: pbrc.edu/news/media/2026/fro… @LSU @LSUCHSE @ololhealth @ololchildrens
4
5
161
But, prevalence of Extreme Obesity (BMI >60) is increasing at alarming rate! pubmed.ncbi.nlm.nih.gov/4028… Obesity meds have only been tested for mean BMI 34. Will need combination of obesity meds + Metabolic Surgery for this group. @ObesitySociety @WorldObesity @ObesityAction @OMAsocial @ASMBS @IfsoSecretariat @JaimePonceMD @jdscottmd @mattars77 @rvcohen @FRubinoMD @metabolic_knife @Ali_Aminian_MD @MichaelAlbertMD
According to a 2026 Gallup poll: Obesity has decreased for the first time in recent history. The trend will continue if patients can afford to GLP-1 medications, patients do not adapt metabolically to the current medications, alternate medications are developed, stigma decreases.
1
8
28
1,343
Philip Schauer, MD retweeted
"Hindsight being 20/20, I would have surgery again." Most respondents said so, but 56% of the unsure or unwilling cited weight recurrence, and only 15% of invitees answered. MBS Digest Vol. 2, Issue 14 also covers GLP-1 agonists after regain and staged SADI-S. Link in reply.
1
1
1
104
Philip Schauer, MD retweeted
LOS Members are invited to an educational dinner with guest speaker Sean Swetledge, PhD. Join us on Wednesday, October 28th at 6:30 pm at One Thirteen Restaurant in Hammond. RSVP using the QR code provided!
1
1
44
That would be an “out of this world” Keynote!
Replying to @elonmusk
@elonmusk could humanoid robots one day surpass expert surgeons in complex surgery? As IFSO President, I would be honored to invite you—or a representative from Tesla or SpaceX—to keynote our World Congress in Paris on August 27, 2027, at 10:30 a.m. before more than 5,000 experienced laparoscopic and robotic surgeons from around the world. Your energy, creativity and vision could inspire the future of surgical care. We would love to explore that future with you. May I send your team a formal invitation? Jaime Ponce, MD IFSO President
1
2
3
363